Intravitreal methotrexate and fluocinolone acetonide implantation for Vogt-Koyanagi-Harada uveitis

Intravitreal methotrexate and fluocinolone acetonide implantation for Vogt-Koyanagi-Harada uveitis

Purpose: To report a case of intravitreal methotrexate treatment and fluocinolone acetonide (Retisert®) implantation in a patient with Vogt-Koyanagi-Harada syndrome (VKH). Observations: A 34-year-old male was referred for worsening vision and bilateral panuveitis consistent with VKH. He was treated...

Full description

Bibliographic Details
Main Authors:	Jong G. Park, Natalia F. Callaway, Cassie A. Ludwig, Vinit B. Mahajan
Format:	Article
Language:	English
Published:	Elsevier 2020-09-01
Series:	American Journal of Ophthalmology Case Reports
Subjects:	Intravitreal methotrexate Fluocinolone acetonide implant Retisert® Vogt-koyanagi-harada syndrome
Online Access:	http://www.sciencedirect.com/science/article/pii/S2451993620301742

Similar Items

Síndrome de Vogt-Koyanagi-Harada
by: Juan Carlos Serna-Ojeda, et al.
Published: (2016-07-01)

Causes analysis of diagnostic errors of Vogt-koyanagi-harada syndrome
by: Yu-Qin Huang, et al.
Published: (2013-10-01)

A rare pediatric case of probable Vogt–Koyanagi–Harada syndrome
by: Malarvizhi Raman, et al.
Published: (2019-01-01)

Three mb. Vogt-koyanagi-harada cases in Slovenia
by: Nataša Vidovič-Valentinčič, et al.
Published: (2005-10-01)

Ocular syphilis mimicking Vogt–Koyanagi–Harada disease
by: Yu-Ching Lin, et al.
Published: (2019-01-01)

Rebound inflammation after an intravitreal injection in Vogt–Koyanagi–Harada syndrome
by: Richa Ranjan, et al.
Published: (2018-01-01)

Bilateral Iris depigmentation, transillumination defects and hypotony in Vogt–Koyanagi–Harada disease
by: Mohit Garg, et al.
Published: (2022-01-01)

Unusual Case of Vogt-Koyanagi-Harada Syndrome Presenting as Non-specific Headache
by: Pradeep A.V., et al.
Published: (2014-04-01)

An unusual presentation of Vogt-Koyanagi-Harada disease
by: R S Keerthhi Dhevi, et al.
Published: (2021-01-01)

Vogt-Koyanagi-Harada Syndrome in a 10 Years Old Child.
by: Aalia R Sufi, et al.
Published: (2011-07-01)

Significant Prognostic Factors for Vogt-Koyanagi-Harada Disease in the Early Stage
by: Shwu-Jiuan Sheu
Published: (2004-03-01)

Presentation of sclerouveitis with features of Vogt Koyanagi Harada syndrome and ocular tuberculosis – A Rare Combination
by: Purva Vijay Deore, et al.
Published: (2022-01-01)

Vogt-Koyanagi-Harada syndrome presenting with encephalopathy
by: Alireza E Naeini, et al.
Published: (2014-01-01)

Vogt-Koyanagi-Harada disease: a retrospective and multicentric study of 41 patients
by: K. Diallo, et al.
Published: (2020-10-01)

Neurosarcoidosis Occurring 6 Years after Onset of Vogt-Koyanagi-Harada Disease
by: Yoshihide Sehara, et al.
Published: (2019-01-01)

Successive onset of Vogt-Koyanagi-Harada syndrome in father and son
by: Hougang Li, et al.
Published: (2023-03-01)

Características de pacientes con enfermedad de Vogt Koyanagi Harada del departamento de reumatología del Hospital de Clínicas
by: Jhonatan Losanto, et al.
Published: (2017-03-01)

Espectro Clínico y Biomarcadores Genéticos de susceptibilidad en el síndrome de Vogt-Koyanagi- Harada en pacientes Paraguayos
by: Nelly Colmán, et al.
Published: (2021-06-01)

A Case of Probable Vogt-Koyanagi-Harada Disease
by: Mutlu Acar, et al.
Published: (2012-05-01)

A rare case of Vogt–Koyanagi–Harada disease presenting simultaneously with pituitary macroadenoma
by: Pradeep Kumar Panigrahi
Published: (2022-01-01)

Indocyanine Green Angiography Guided Management of Vogt-Koyanagi-Harada Disease
by: Nadia Bouchenaki, et al.
Published: (2011-01-01)

Hints from the skin beneath: Vitiligo in Vogt–Koyanagi–Harada disease
by: Jo Anne Lim, et al.
Published: (2022-01-01)

Vogt–Koyanagi–Harada disease in a patient of chronic myeloid leukemia
by: Rohan Chawla, et al.
Published: (2017-01-01)

Acute-onset Vogt-Koyanagi-Harada like uveitis following Covid-19 inactivated virus vaccination
by: Xiuju Chen, et al.
Published: (2022-06-01)

Choroidal Excavation in Vogt-Koyanagi-Harada Disease
by: Noriyasu Hashida, et al.
Published: (2014-07-01)

Vogt-Koyanagi-Harada syndrome presenting with encephalopathy
by: Alireza E Naeini, et al.
Published: (2013-01-01)

Vogt-Koyanagi-Harada's disease: literature review
by: Pereira, Talita Valleska de Campos, et al.
Published: (2008-09-01)

Macular Hole Associated with Vogt-Koyanagi-Harada Disease at the Acute Uveitic Stage
by: Masaharu Mizuno, et al.
Published: (2015-09-01)

Clinical spectrum and management options in Vogt–Koyanagi–Harada disease
by: Lodhi SA, et al.
Published: (2017-08-01)

Common practice patterns in the diagnosis and management of Vogt–Koyanagi–Harada syndrome: a survey study of uveitis specialists
by: Charlene H. Choo, et al.
Published: (2023-07-01)

Vogt-Koyanagi-Harada disease following influenza vaccination
by: Fahmeeda Murtaza, et al.
Published: (2022-06-01)

Phacoemulsification after trabeculectomy in uveitis associated with Vogt-Koyanagi-Harada disease: intermediate-term visual outcome, IOP control and trabeculectomy survival
by: Faisal A. Almobarak, et al.
Published: (2022-05-01)

Recurrent Vogt-Koyanagi-Harada disease presenting with diffuse orbital inflammation
by: Brandon Fram, et al.
Published: (2022-09-01)

Advances in treatment of Vogt-Koyanagi-Harada syndrome
by: Guo Huang, et al.
Published: (2017-06-01)

Preliminary research on plasma microRNA profiling in patients with Vogt-Koyanagi-Harada syndrome
by: Xin-Qiao Zhang, et al.
Published: (2016-04-01)

Study and analysis of Vogt-Koyanagi-Harada syndrome by fundus fluorescein angiography
by: Fang Cao
Published: (2014-08-01)

Vogt-Koyanagi-Harada Disease and COVID
by: Priscilla Manni, et al.
Published: (2023-09-01)

Tofacitinib in Vogt-Koyanagi-Harada disease
by: Parthopratim Dutta Majumder, et al.
Published: (2020-01-01)

Adalimumab in Vogt-Koyanagi-Harada Disease Refractory to Conventional Therapy
by: Shizhao Yang, et al.
Published: (2022-01-01)

Identification of Urine Metabolic Biomarkers for Vogt-Koyanagi-Harada Disease
by: Rui Chang, et al.
Published: (2021-02-01)